Bioabsorbable stent
    1.
    发明授权

    公开(公告)号:US11135075B2

    公开(公告)日:2021-10-05

    申请号:US16525123

    申请日:2019-07-29

    IPC分类号: A61F2/915

    摘要: To provide a bioabsorbable stent including: a first tubular unit containing a plurality of cells coupled to each other, each of the cells formed from substantially linear parts and a substantially circular arc part and having a substantially U shape which opens to one end in the axial direction of the stent; and a second tubular unit having the same shape as that of the first tubular unit, the second tubular unit containing a plurality of cells each of which has a substantially U shape which opens to a direction opposite to the opening direction of the opposing first cell. The first tubular unit and the second tubular unit are alternately arranged in sequence to surround a central axis of the stent. Coupling members couple substantially linear parts in some of the opposing cells in the respective neighboring tubular units.

    Erythropoietin Expression Promoter
    2.
    发明申请
    Erythropoietin Expression Promoter 有权
    红细胞生成素表达启动子

    公开(公告)号:US20150353489A1

    公开(公告)日:2015-12-10

    申请号:US14646640

    申请日:2013-11-25

    摘要: The present invention provides an erythropoietin expression-enhancing agent that can cancel the suppression of erythropoietin production or promote erythropoietin production, and a therapeutic or preventive drug for anemia, a liver function-improving agent, an ischemic injury-improving agent, a renal protective agent, and an insulin secretagogue comprising the erythropoietin expression-enhancing agent. The erythropoietin expression-enhancing agent of the present invention comprises one or more compounds selected from the group consisting of compounds represented by the following general formulas (I), (II), and (III) and pharmaceutically acceptable salts thereof when R3 is OH.

    摘要翻译: 本发明提供可以消除促红细胞生成素抑制或促进红细胞生成素产生的促红细胞生成素表达增强剂,以及用于贫血的治疗或预防药物,肝功能改善剂,缺血性损伤改善剂,肾保护剂 和包含促红细胞生成素表达增强剂的胰岛素促分泌素。 本发明的促红细胞生成素表达增强剂含有一种或多种选自由以下通式(I),(II)和(III)表示的化合物及其当R 3为OH时的药学上可接受的盐的化合物。

    GAS SENSOR ARRAY, GAS ANALYSIS METHOD, AND GAS ANALYSIS SYSTEM
    3.
    发明申请
    GAS SENSOR ARRAY, GAS ANALYSIS METHOD, AND GAS ANALYSIS SYSTEM 有权
    气体传感器阵列,气体分析方法和气体分析系统

    公开(公告)号:US20150308972A1

    公开(公告)日:2015-10-29

    申请号:US14425560

    申请日:2013-09-02

    发明人: Norio AKIYAMA

    IPC分类号: G01N27/12 G01N33/00

    摘要: A gas sensor array containing a gas flow path in which a gas to be analyzed flows, and a plurality of gas sensors set along the gas flowing direction of the gas flow path, wherein the gas sensors each has a constitution wherein semiconductor microcrystals that come into contact with the gas to be analyzed that flows in the above gas flow path are disposed between two electrodes.

    摘要翻译: 一种包含气体流路的气体传感器阵列,其中待分析的气体流动,沿着气体流路的气体流动方向设置多个气体传感器,其中气体传感器各自具有其中进入的半导体微晶体 与在上述气体流路中流动的待分析气体接触配置在两个电极之间。

    Gas sensor and gas sensor array
    7.
    发明授权

    公开(公告)号:US10830723B2

    公开(公告)日:2020-11-10

    申请号:US15323183

    申请日:2015-07-03

    发明人: Norio Akiyama

    摘要: A gas sensor containing counter electrodes and a semiconductor nanowire 4 disposed between the counter electrodes 2, 3, wherein the semiconductor nanowire 4 is in a state where light can be irradiated, which sensor measures changes in the electric current associated with adsorption of a gas to the semiconductor nanowire 4, wherein the electric current is generated by irradiation of light on the semiconductor nanowire with a voltage applied to the counter electrodes 2, 3.

    BIOABSORBABLE STENT
    9.
    发明申请
    BIOABSORBABLE STENT 审中-公开

    公开(公告)号:US20190350732A1

    公开(公告)日:2019-11-21

    申请号:US16525123

    申请日:2019-07-29

    IPC分类号: A61F2/915

    摘要: To provide a bioabsorbable stent including: a first tubular unit containing a plurality of cells coupled to each other, each of the cells formed from substantially linear parts and a substantially circular arc part and having a substantially U shape which opens to one end in the axial direction of the stent; and a second tubular unit having the same shape as that of the first tubular unit, the second tubular unit containing a plurality of cells each of which has a substantially U shape which opens to a direction opposite to the opening direction of the opposing first cell. The first tubular unit and the second tubular unit are alternately arranged in sequence to surround a central axis of the stent. Coupling members couple substantially linear parts in some of the opposing cells in the respective neighboring tubular units.